Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review

BACKGROUND: Gut microbiome (GM) composition and diversity have recently been studied as a biomarker of response to immune checkpoint blockade therapy (ICB) and of ICB-related colitis. AIM: To conduct a systematic review on the role of GM composition and diversity in predicting response and colitis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Oey, Oliver, Liu, Yu-Yang, Sunjaya, Angela Felicia, Simadibrata, Daniel Martin, Khattak, Muhammad Adnan, Gray, Elin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724183/
https://www.ncbi.nlm.nih.gov/pubmed/36483977
http://dx.doi.org/10.5306/wjco.v13.i11.929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724183/
https://www.ncbi.nlm.nih.gov/pubmed/36483977
http://dx.doi.org/10.5306/wjco.v13.i11.929

Ejemplares similares